ArticleGastroenterology report2022

Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model.

Sang Hyun Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.